US EditionPublished • loading... • Updated
Developer To Finish Life Sciences Scheme After Merck Backs Out Of 180K SF Lab Commitment
Summary by Bisnow
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Developer To Finish Life Sciences Scheme After Merck Backs Out Of 180K SF Lab Commitment
The low-profile developer behind a major King’s Cross life sciences scheme will push on and complete the project, even after global pharmaceutical giant Merck pulled out of the building. Merck said on Thursday that it would not occupy the 180K SF Belgrove House building because the UK was “not competitive” for pharmaceutical companies due to the lower price of drugs compared to other countries. Merck's lease is still intact.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
